Received May 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
experienced some palm and feet itching; unwell feeling; This non-serious case was reported by a consumer via call center representative and described the occurrence of localized itching in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced localized itching (Verbatim: experienced some palm and feet itching) and feeling unwell (Verbatim: unwell feeling). The outcome of the localized itching and feeling unwell were not reported. It was unknown if the reporter considered the localized itching and feeling unwell to be related to Shingrix. It was unknown if the company considered the localized itching and feeling unwell to be related to Shingrix. Additional Information: GSK Receipt Date: 07-MAY-2026 Patient had the first shingles vaccine right before Covid hit and never got the second shot, wanted to know if he/she can get the second shot anytime. Also experienced some palm and feet itching after the first shot as well as an unwell feeling. The batch number was not provided upon follow- up with the reporter.